These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 20687444)

  • 1. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].
    de Brouckère V; Liénart F; Ducobu J
    Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers?
    Koschinsky ML
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):267-78. PubMed ID: 17378772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
    Dieplinger H; Kronenberg F
    Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].
    Couderc R; Maachi M
    J Mal Vasc; 1998 Jun; 23(3):165-75. PubMed ID: 9669219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipoprotein(a) as a cardiovascular risk factor].
    van Lennep JE; Mulder MT
    Ned Tijdschr Geneeskd; 2011; 155(42):A3582. PubMed ID: 22027461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical evaluation of the role of Lp(a) in cardiovascular disease: can Lp(a) be useful in risk assessment?
    Marcovina SM; Koschinsky ML
    Semin Vasc Med; 2002 Aug; 2(3):335-44. PubMed ID: 16222623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) as a risk factor for coronary artery disease.
    Marcovina SM; Koschinsky ML
    Am J Cardiol; 1998 Dec; 82(12A):57U-66U; discussion 86U. PubMed ID: 9915664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1994 Dec; (77):51-8. PubMed ID: 19496273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1996 Jan; 77A():54-61. PubMed ID: 8729591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
    Armstrong VW
    Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function.
    Scanu AM
    J Lab Clin Med; 1990 Aug; 116(2):142-6. PubMed ID: 2144311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
    Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
    J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein (a)--a mysterious factor in atherogenesis].
    Jelaković B; Laganović M; Kuzmanić D
    Lijec Vjesn; 2002; 124(11-12):366-71. PubMed ID: 12679978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a): a unique risk factor for cardiovascular disease.
    Anuurad E; Boffa MB; Koschinsky ML; Berglund L
    Clin Lab Med; 2006 Dec; 26(4):751-72. PubMed ID: 17110238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoprotein(a) as an athero-thrombotic risk factor: epidemiologic evidence and possible pathogenetic mechanisms].
    Lenzi S; Scanu A; De Caterina R
    G Ital Cardiol; 1996 Oct; 26(10):1203-25. PubMed ID: 9005165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk.
    Discepolo W; Wun T; Berglund L
    Pathophysiol Haemost Thromb; 2006; 35(3-4):314-21. PubMed ID: 16877880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
    Scanu AM
    Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
    Tsimikas S; Tsironis LD; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.